The latest price target for Cardio Diagnostics Hldgs (NASDAQ:CDIO) was reported by Benchmark on August 27, 2024. The analyst firm set a price target for $2.00 expecting CDIO to rise to within 12 months (a possible 98.02% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Cardio Diagnostics Hldgs (NASDAQ:CDIO) was provided by Benchmark, and Cardio Diagnostics Hldgs reiterated their speculative buy rating.

There is no last upgrade for Cardio Diagnostics Hldgs

There is no last downgrade for Cardio Diagnostics Hldgs.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardio Diagnostics Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardio Diagnostics Hldgs was filed on August 27, 2024 so you should expect the next rating to be made available sometime around August 27, 2025.

While ratings are subjective and will change, the latest Cardio Diagnostics Hldgs (CDIO) rating was a reiterated with a price target of $2.00 to $2.00. The current price Cardio Diagnostics Hldgs (CDIO) is trading at is $1.01, which is out of the analyst’s predicted range.